{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:29:36Z","timestamp":1785583776670,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012023","name":"Sanquin Blood Supply Foundation","doi-asserted-by":"crossref","award":["PPOC18-15\/L2338"],"award-info":[{"award-number":["PPOC18-15\/L2338"]}],"id":[{"id":"10.13039\/501100012023","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Blood donors are at risk for reduced iron stores, because of which donor iron monitoring received increased attention in the last decade. Despite the importance for donor health, international consensus on an appropriate policy for iron monitoring is lacking. Therefore, we conduct a trial to evaluate to what extent ferritin-guided donation intervals are effective in increasing haemoglobin and ferritin levels, decreasing low-haemoglobin deferral, increasing donor return and improving the health of whole blood donors in the Netherlands.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Sanquin Blood Bank is implementing ferritin-guided donation intervals to prevent donors from increasing iron loss at repeated donations. Using a stepped wedge cluster randomised trial approach, the design involves a random crossover of 29 clusters of blood collection centres from the existing policy without ferritin measurements to a ferritin-guided donation interval policy. This new policy includes ferritin measurements for all new donors and at every 5th whole blood donation, extending donation intervals to 6\u00a0months if ferritin is 15\u2013\u2264\u200930\u2009ng\/mL and to 12\u00a0months if ferritin is &lt;\u200915\u2009ng\/mL. We measure ferritin levels of whole blood donors from stored plasma samples and collect haemoglobin levels and information on low-haemoglobin deferral and donor return from the donor database before, during and after the implementation period. We measure donor health during and after the implementation period using questionnaires, assessing physical and mental wellbeing and iron deficiency- and donation-related symptoms. We use multilevel analyses to investigate differences in ferritin and haemoglobin levels, low-haemoglobin deferral rates, donor return and donor health from whole blood donors, between blood collection centres that have versus those that have not yet implemented the ferritin-guided donation interval policy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>This stepped wedge cluster randomised trial will provide insight into the effectiveness of ferritin-guided donation intervals in lowering iron deficiency, decreasing donor deferrals due to low haemoglobin and improving donor health. We will evaluate a policy that is implemented nationwide in a real-life setting. Our study is therefore not limited to a small experimental setting and the results will guide policymakers seeking an appropriate policy for iron monitoring.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>The Dutch trial registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.trialregister.nl\/trial\/6549\">NTR6738<\/jats:ext-link>. Registered on 29 September 2017. Retrospectively registered.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13063-020-04648-w","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T01:03:09Z","timestamp":1601514189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ferritin measurement IN Donors\u2014Effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND\u2019EM): study protocol for a stepped wedge cluster randomised trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-4061","authenticated-orcid":false,"given":"Maike G.","family":"Sweegers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Zalpuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franke A.","family":"Quee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M. J.","family":"Huis in \u2018t Veld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femmeke J.","family":"Prinsze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel O.","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. R.","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton W. M.","family":"van Weert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim L. A. M.","family":"de Kort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"4648_CR1","first-page":"77","volume":"120","author":"GM Brittenham","year":"2005","unstructured":"Brittenham GM. Iron balance in the red blood cell donor. Dev Biol (Basel). 2005;120:77\u201382.","journal-title":"Dev Biol (Basel)"},{"issue":"1","key":"4648_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-3148.2007.00818.x","volume":"18","author":"F Boulton","year":"2008","unstructured":"Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med. 2008;18(1):13\u201327.","journal-title":"Transfus Med"},{"issue":"10","key":"4648_CR3","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/j.1537-2995.2006.00969.x","volume":"46","author":"B Newman","year":"2006","unstructured":"Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion. 2006;46(10):1667\u201381.","journal-title":"Transfusion"},{"issue":"6","key":"4648_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/MOH.0b013e32836589f2","volume":"20","author":"B Spencer","year":"2013","unstructured":"Spencer B. Blood donor iron status: are we bleeding them dry? Curr Opin Hematol. 2013;20(6):533\u20139.","journal-title":"Curr Opin Hematol"},{"issue":"17","key":"4648_CR5","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1182\/blood-2016-04-709451","volume":"128","author":"N Schotten","year":"2016","unstructured":"Schotten N, Pasker-de Jong PC, Moretti D, Zimmermann MB, Geurts-Moespot AJ, Swinkels DW, et al. The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128(17):2185\u20138.","journal-title":"Blood"},{"key":"4648_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/1745-6215-15-363","volume":"15","author":"C Moore","year":"2014","unstructured":"Moore C, Sambrook J, Walker M, Tolkien Z, Kaptoge S, Allen D, et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials. 2014;15:363.","journal-title":"Trials"},{"issue":"1","key":"4648_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/trf.14935","volume":"59","author":"A Dijkstra","year":"2019","unstructured":"Dijkstra A, van den Hurk K, Bilo HJG, Slingerland RJ, Vos MJ. Repeat whole blood donors with a ferritin level of 30 mug\/L or less show functional iron depletion. Transfusion. 2019;59(1):21\u20135.","journal-title":"Transfusion"},{"issue":"10110","key":"4648_CR8","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/S0140-6736(17)31928-1","volume":"390","author":"E Di Angelantonio","year":"2017","unstructured":"Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet. 2017;390(10110):2360\u201371.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"4648_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1741-6892.2004.00448.x","volume":"87","author":"F Boulton","year":"2004","unstructured":"Boulton F. Managing donors and iron deficiency. Vox Sang. 2004;87(Suppl 2):22\u20134.","journal-title":"Vox Sang"},{"issue":"9","key":"4648_CR10","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2002-10-3071","volume":"101","author":"JD Cook","year":"2003","unstructured":"Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359\u201364.","journal-title":"Blood"},{"key":"4648_CR11","volume-title":"Guidelines on assessing donor suitability for blood donation. blood donor selection","author":"WHO","year":"2012","unstructured":"WHO. Guidelines on assessing donor suitability for blood donation. blood donor selection. Geneva: World Health Organisation; Guidelines Approved by the Guidelines Review Committee; 2012."},{"issue":"2","key":"4648_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-3148.2000.00239.x","volume":"10","author":"L Alvarez-Ossorio","year":"2000","unstructured":"Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med. 2000;10(2):107\u201312.","journal-title":"Transfus Med"},{"issue":"11","key":"4648_CR13","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1111\/trf.13195","volume":"55","author":"AM Baart","year":"2015","unstructured":"Baart AM, van den Hurk K, de Kort WL. Minimum donation intervals should be reconsidered to decrease low hemoglobin deferral in whole blood donors: an observational study. Transfusion. 2015;55(11):2641\u20134.","journal-title":"Transfusion"},{"key":"4648_CR14","doi-asserted-by":"publisher","first-page":"h391","DOI":"10.1136\/bmj.h391","volume":"350","author":"K Hemming","year":"2015","unstructured":"Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391.","journal-title":"BMJ"},{"key":"4648_CR15","unstructured":"European Directorate for the Quality of Medicines and HealthCare. Guide for the preparation, use and quality assurance of blood components. Councel Eur. 2015."},{"issue":"5","key":"4648_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1515\/CCLM.2009.121","volume":"47","author":"RE Gislefoss","year":"2009","unstructured":"Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med. 2009;47(5):596\u2013603.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"4648_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"5","key":"4648_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","volume":"38","author":"JH Vercoulen","year":"1994","unstructured":"Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383\u201392.","journal-title":"J Psychosom Res"},{"issue":"5","key":"4648_CR19","first-page":"405","volume":"15","author":"K Van den Hurk","year":"2017","unstructured":"Van den Hurk K, Peffer K, Habets K, Atsma F, Pasker-de Jong PCM, Van Noord PAH, et al. Blood donors\u2019 physical characteristics are associated with pre- and post-donation symptoms - Donor InSight. Blood Transfus. 2017;15(5):405\u201312.","journal-title":"Blood Transfus"},{"issue":"2","key":"4648_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1537-2995.2011.03279.x","volume":"52","author":"E Ferguson","year":"2012","unstructured":"Ferguson E, Atsma F, de Kort W, Veldhuizen I. Exploring the pattern of blood donor beliefs in first-time, novice, and experienced donors: differentiating reluctant altruism, pure altruism, impure altruism, and warm glow. Transfusion. 2012;52(2):343\u201355.","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"4648_CR21","doi-asserted-by":"publisher","first-page":"O87","DOI":"10.1186\/1745-6215-14-S1-O87","volume":"14","author":"T Dreischulte","year":"2013","unstructured":"Dreischulte T, Grant A, Donnan P, Guthrie B. Pro\u2019s and con\u2019s of the stepped wedge design in cluster randomised trials of quality improvement interventions: two current examples. Trials. 2013;14(Suppl 1):O87.","journal-title":"Trials"},{"key":"4648_CR22","doi-asserted-by":"publisher","first-page":"i4291","DOI":"10.1136\/bmj.i4291","volume":"354","author":"A Caille","year":"2016","unstructured":"Caille A, Kerry S, Tavernier E, Leyrat C, Eldridge S, Giraudeau B. Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials. BMJ. 2016;354:i4291.","journal-title":"BMJ"},{"key":"4648_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jclinepi.2015.08.015","volume":"69","author":"K Hemming","year":"2016","unstructured":"Hemming K, Taljaard M. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach. J Clin Epidemiol. 2016;69:137\u201346.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"4648_CR24","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/trf.13152","volume":"55","author":"K Magnussen","year":"2015","unstructured":"Magnussen K, Ladelund S. Handling low hemoglobin and iron deficiency in a blood donor population: 2 years\u2019 experience. Transfusion. 2015;55(10):2473\u20138.","journal-title":"Transfusion"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:55:21Z","timestamp":1633053321000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04648-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sanquin\u2019s Ethical Advisory Board has approved the FIND\u2019EM protocol and considered the study not to fall within the scope of the Medical Research Involving Human Subjects Act. For the outcomes Hb and ferritin levels, low-Hb deferral and donor return, we only include donors who gave consent for their information and left-over material to be used for research purposes. For the outcome donor health, we only use data from donors who provided consent for their questionnaire data to be matched with data from the donor database.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"823"}}